|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1064
|
$984B |
15.4x |
34.1x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$204
|
$520B |
5.5x |
14.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$220
|
$452B |
7.4x |
17.3x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 342
|
$368B |
4.7x |
12.0x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£142
|
$321B |
5.5x |
15.8x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$111
|
$297B |
4.6x |
10.0x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 114
|
$297B |
5.4x |
13.1x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 381
|
$276B |
5.7x |
11.8x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$326
|
$221B |
6.1x |
12.5x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$191B |
3.1x |
7.7x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$121
|
$168B |
5.7x |
10.5x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$56
|
$148B |
3.1x |
7.9x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€84
|
$128B |
2.4x |
8.1x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£19
|
$122B |
2.8x |
8.3x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$464
|
$113B |
9.4x |
21.0x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8421
|
$82.8B |
10.4x |
20.5x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€39
|
$82.7B |
1.6x |
7.4x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5080
|
$76.1B |
2.6x |
9.8x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€128
|
$75.9B |
3.1x |
10.7x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 174
|
$66.2B |
4.1x |
12.2x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$127
|
$61.2B |
6.5x |
14.9x |
|
Jiangsu Hengrui Pharma
|
Hong Kong |
Biopharmaceuticals
|
HKD 71
|
$54.9B |
11.8x |
39.3x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 64
|
$54.9B |
11.6x |
38.5x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 554
|
$53.3B |
5.6x |
19.2x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 104
|
$52.5B |
3.0x |
10.3x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1730
|
$43.5B |
7.0x |
24.4x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3542
|
$39.3B |
3.0x |
14.8x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 61
|
$37.0B |
3.4x |
15.6x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 217000
|
$34.1B |
12.0x |
33.3x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$188
|
$30.2B |
3.1x |
9.9x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9090
|
$28.7B |
1.9x |
7.7x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2237
|
$28.4B |
2.2x |
9.4x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$28.3B |
2.0x |
6.9x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 42
|
$27.9B |
13.2x |
34.4x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$40
|
$24.3B |
8.2x |
8.4x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.5B |
2.2x |
6.3x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 344
|
$19.9B |
63.1x |
N/A |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 89
|
$18.9B |
9.7x |
95.7x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 511000
|
$18.6B |
120.0x |
223.5x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2182
|
$17.7B |
4.9x |
12.7x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.7B |
2.0x |
8.3x |
|
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3963
|
$15.1B |
10.8x |
32.7x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 128
|
$14.7B |
31.1x |
-1464.6x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$14.6B |
3.0x |
11.3x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 348
|
$14.4B |
4.6x |
12.1x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€50
|
$14.2B |
4.6x |
12.4x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 476
|
$13.6B |
48.7x |
-294.8x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 26
|
$13.2B |
2.3x |
13.9x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$136
|
$12.9B |
4.5x |
19.5x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.8B |
2.1x |
14.5x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2907
|
$12.2B |
4.0x |
9.8x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$12.2B |
3.0x |
12.2x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1466
|
$12.1B |
3.8x |
15.6x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.7B |
0.3x |
5.0x |
|
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€225
|
$11.7B |
N/A |
N/A |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€127
|
$11.6B |
2.6x |
6.9x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1209
|
$11.1B |
2.9x |
12.0x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2181
|
$11.0B |
3.9x |
15.4x |
|
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 26
|
$11.0B |
3.3x |
7.8x |
|
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 71
|
$10.9B |
12.7x |
41.5x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€66
|
$10.9B |
5.0x |
13.3x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2200
|
$10.6B |
6.9x |
27.4x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$10.2B |
1.6x |
5.3x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 895
|
$10.2B |
3.7x |
13.2x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 40
|
$9.6B |
1.5x |
12.1x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$72
|
$9.3B |
7.0x |
10.6x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€99
|
$8.4B |
832.3x |
-35.3x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4767
|
$8.2B |
1.6x |
13.0x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 44
|
$8.2B |
N/A |
N/A |
|
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 59
|
$8.1B |
N/A |
N/A |
|
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 28
|
$7.8B |
2.9x |
4.2x |
|
ABL Bio
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 204500
|
$7.7B |
98.3x |
17214.4x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$288
|
$7.6B |
25568.0x |
-25.7x |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1199
|
$7.6B |
2.1x |
10.1x |
|
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 103
|
$7.5B |
18.5x |
-3089.3x |
|
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 380
|
$7.5B |
4.0x |
19.1x |
|
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5799
|
$7.4B |
4.7x |
23.5x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2571
|
$7.1B |
2.3x |
10.2x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€214
|
$6.9B |
2.9x |
8.8x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$6.6B |
2.2x |
9.6x |
|
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 29
|
$6.5B |
1.5x |
8.7x |
|
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2272
|
$6.5B |
2.0x |
8.6x |
|
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 28043
|
$6.4B |
8.5x |
30.9x |
|
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 6
|
$6.3B |
N/A |
N/A |
|
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 363
|
$6.2B |
N/A |
N/A |
|
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2007
|
$6.1B |
3.4x |
22.9x |
|
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 150
|
$6.0B |
16.7x |
24.9x |
|
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£16
|
$6.0B |
1.8x |
7.1x |
|
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 113120
|
$5.8B |
3.8x |
42.8x |
|
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 63
|
$5.8B |
6.7x |
23.4x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$158
|
$5.7B |
N/A |
N/A |
|
Gan and Lee
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 71
|
$5.6B |
9.3x |
28.0x |
|
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 98
|
$5.4B |
2.7x |
10.3x |
|
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10280
|
$5.3B |
1.9x |
5.2x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$35
|
$5.2B |
N/A |
-19.3x |
|
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 39
|
$5.1B |
14.1x |
-76.6x |
|
Henlius Biotech
|
Hong Kong |
Biopharmaceuticals
|
HKD 67
|
$5.1B |
6.0x |
30.4x |
|
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 117
|
$5.0B |
1.9x |
10.9x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$108
|
$4.8B |
N/A |
-29.2x |
|
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 512
|
$4.8B |
9.8x |
29.6x |